Join us in celebrating the strength and resilience of cancer survivors and learn more about how we’re challenging the notion of what’s possible in rare cancer treatment: https://bit.ly/3KeyD1c #NationalCancerSurvivorsDay
PharmaEssentia’s Post
More Relevant Posts
-
🚀 AI is revolutionizing cancer diagnosis, treatment, and patient care. David Woods and Kelly Malloy from Inizio Medical translate what that means for pharmaceutical organizations and how they must position themselves to succeed with AI in this transformative landscape. 🌐 Read now: https://lnkd.in/eTnVXgBv #AIMedTech #OncologyInnovation #HealthcareTransformation
To view or add a comment, sign in
-
🌟 Biotech Medical Affairs Roundtable: Self-Commercialization in Oncology 🌟 Experts Christopher Jones, Zack Lentz, and Sally Alexandroff explore the challenges biotech firms face in commercializing oncology therapies and the crucial role medical affairs play in their success. Read our latest article here 👉 https://lnkd.in/eiYCBY9u. #Biotech #Oncology #MedicalAffairs #Pharma #HealthcareInnovation
To view or add a comment, sign in
-
Read Abby Mallon's article in BioPharma Dive https://lnkd.in/gkNwJGx4 to see how #NurseNavigators and #ClinicalNurseEducators can improve #MedicationAdherence and #PatientEngagement in the oncology space – particularly as more oral therapeutics enter the market.
To view or add a comment, sign in
-
Are the brands focusing on the right areas when providing adherence support to their patients? According to PURE Engagement, Physicians consider the drugs’ side effects to be the main reason for patients to discontinue a drug where financial burden is ranked #3. To find out what other factors physicans contribute to drug drop off or to learn more, see: https://lnkd.in/edZbfiUE #Oncology #Pharma #Adherence #PURE
To view or add a comment, sign in
-
#ExcelraforAI Can immunotherapy revolutionize treatment for cancer patients? Our California-based pharmaceutical client faced challenge in pinpointing which patients would benefit most from their immunotherapy drugs. Thanks to AI-powered solutions, they can now accurately identify responders and non-responders, leading to Improved treatment efficacy, Enhanced patient safety, and Optimized clinical trials. With 89% accuracy in predictions, we're making personalized cancer care a reality. Read our case study to learn more about how we’re transforming patient outcomes through cutting-edge technology: https://hubs.la/Q02JyDKl0 #Immunotherapy #AI #Healthcare #Excelra #lifescience #biotech #drugdiscovery Bindu Ajithkumar Jitendra Parekh Sumona Mitra Adi Ghosh Uzma Saeed
To view or add a comment, sign in
-
💡 Join Biofourmis's webinar to explore the vast potential of #digitalhealth in oncology care. Despite the digital health market growing to $221 billion by 2026 and cancer care projected to cost $246 billion by 2030, digital solutions currently represent only 3% of oncology care volume. Learn how pharmaceutical and life science technology companies are collaborating to harness digital health tools in oncology care delivery. ➡️ REGISTER HERE: https://buff.ly/3Sk14Qa #ClinicalData #TherapeuticAreas #DigitalHealthTechnology #DigitalTransformation #DigitalTechnologies #DigitalHealthcare
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Exelixis’ Cabometyx misses survival endpoint, but will still file in prostate cancer >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #pharma #productmarketing #healthcare
Exelixis’ Cabometyx misses survival endpoint, but will still file in prostate cancer
endpts.com
To view or add a comment, sign in
-
Was ASCO GI 2024 practice changing or more of the same? Check out our team's quick take. DM me if you need more details or further analysis. Analysis by tumor type coming soon (DM for an early preview)
📢 Explore the future of oncology with our latest white paper 📰 , delving into groundbreaking research, innovative therapies, and the evolving landscape of cancer treatment. To gain valuable insights and stay ahead in the rapidly advancing field of oncology, visit our website🌐https://lnkd.in/gWauZswf for more information. #Oncology #CancerResearch #InnovationInHealthcare #WhitePaper #GI24 #asco #conference #pharmanews #pharmaceutical #healthcare #pharmaceuticalindustry
To view or add a comment, sign in
-
Thoughts on this? >> Exelixis’ Cabometyx misses survival endpoint, but will still file in prostate cancer >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #productmarketing #biotech #pharma #pharmaceutical
Exelixis’ Cabometyx misses survival endpoint, but will still file in prostate cancer
endpts.com
To view or add a comment, sign in
-
Artificial intelligence (AI) is revolutionizing the field of oncology, delivering groundbreaking results from drug development to early cancer detection. By leveraging advanced AI technologies, the pharmaceutical and healthcare sectors are accelerating the development of cancer treatments, improving diagnostic accuracy, and ultimately offering better outcomes for patients. To know more details regarding how AI can transforn in the field of Oncology, click the below link and follow Maven Scientific Laboratories Pvt Ltd https://lnkd.in/gRcE2YbY #AIinOncology #CancerDetectionAI #DrugDevelopmentAI #CancerDiagnosticsAI #MachineLearningInOncology #AICancerTreatment #AIDrugDiscovery #OncologyAdvancements #PersonalizedCancerTherapy #AICancerResearch #PrecisionMedicine #CancerTherapies
To view or add a comment, sign in
10,948 followers